Menicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear; ACUVUE® Abiliti™ Overnight and ACUVUE® Abiliti™ Overni

FDA Premarket Approval P990018 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceMenicon Z Night (tisilfocon A) Contact Lenses for Overnight Wear; ACUVUE® Abiliti™ Overnight and ACUVUE® Abiliti™ Overni
Generic NameLens, Contact, Orthokeratology, Overnight
ApplicantMENICON CO. LTD.21-19, Aoi 3-chome, Naka-kunagoya Aichi 460-0-0006 PMA NumberP990018 Supplement NumberS008 Date Received02/07/2022 Decision Date08/02/2022 Product Codes MWL NUU  Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No
Date Received2022-02-07
Decision Date2022-08-02
PMAP990018
SupplementS008
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination ProductNo
Applicant AddressMENICON CO. LTD.
21-19, Aoi 3-chome, Naka-ku
nagoya Aichi 460-0-0006 PMA NumberP990018 Supplement NumberS008 Date Received02/07/2022 Decision Date08/02/2022 Product Codes MWL NUU  Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement  
approval For An Expanded Range Of Myopia Treatment Of Up To 6.00 Diopters (manifest Spherical Equivalent)

Supplemental Filings

Supplement NumberDateSupplement Type
P990018Original Filing
S008 2022-02-07 Normal 180 Day Track
S007
S006 2021-01-21 Normal 180 Day Track No User Fee
S005 2018-11-28 Normal 180 Day Track
S004 2009-04-01 Normal 180 Day Track No User Fee
S003 2002-10-21 Real-time Process
S002 2001-11-28 Panel Track
S001 2000-07-28 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.